| 818 |
Tabun
|
|
559: Inhibition of acetylcholinesterase (AChE) leading to arrhythmias
|
| 819 |
Carbaryl
|
|
559: Inhibition of acetylcholinesterase (AChE) leading to arrhythmias
|
| 820 |
Aldicarb
|
|
559: Inhibition of acetylcholinesterase (AChE) leading to arrhythmias
|
| 821 |
Physostigmine
|
|
559: Inhibition of acetylcholinesterase (AChE) leading to arrhythmias
|
| 822 |
Carbofuran
|
|
559: Inhibition of acetylcholinesterase (AChE) leading to arrhythmias
|
| 823 |
Pilocarpine
|
|
559: Inhibition of acetylcholinesterase (AChE) leading to arrhythmias
|
| 824 |
Bethanechol
|
|
559: Inhibition of acetylcholinesterase (AChE) leading to arrhythmias
|
| 825 |
Isobutylmethylxanthine
|
-
Isobutylmethylxanthine, CAS-RN: 28822-58-4, DTXSID0040549
|
561: Aromatase induction leading to estrogen receptor alpha activation via increased estradiol
|
| 826 |
Aldrin
|
-
Aldrin, CAS-RN: 309-00-2, DTXSID8020040
|
561: Aromatase induction leading to estrogen receptor alpha activation via increased estradiol
|
| 827 |
Technical chlordane
|
-
Technical chlordane, CAS-RN: 12789-03-6, DTXSID5023954
|
561: Aromatase induction leading to estrogen receptor alpha activation via increased estradiol
|
| 828 |
Methoxychlor
|
-
Methoxychlor, CAS-RN: 72-43-5, DTXSID9020827
|
561: Aromatase induction leading to estrogen receptor alpha activation via increased estradiol
|
| 829 |
Oxadiazon
|
-
Oxadiazon, CAS-RN: 19666-30-9, DTXSID3024239
|
561: Aromatase induction leading to estrogen receptor alpha activation via increased estradiol
|
| 830 |
Metolachlor
|
-
Metolachlor, CAS-RN: 51218-45-2, DTXSID4022448
|
561: Aromatase induction leading to estrogen receptor alpha activation via increased estradiol
|
| 831 |
Cilobradine
|
|
562: HCN Channel Inhibition leading to Arrhythmias
|
| 832 |
4-bromo-2-(methylamino)-benzimidazole
|
|
562: HCN Channel Inhibition leading to Arrhythmias
|
| 833 |
N-Methyl-D-aspartic acid
|
-
N-Methyl-D-aspartic acid, CAS-RN: 6384-92-5, DTXSID8041082
|
475: Binding of chemicals to ionotropic glutamate receptors leads to impairment of learning and memory via loss of drebrin from dendritic spines of neurons
|
| 835 |
3,3',5,5'-Tetrabromobisphenol A
|
-
3,3',5,5'-Tetrabromobisphenol A, CAS-RN: 79-94-7, DTXSID1026081
|
565: 17β-Hydroxysteroid dehydrogenase 2, inhibition leading to activation, estrogen receptor alpha
|
| 836 |
7,12-Dimethylbenz(a)anthracene
|
-
7,12-Dimethylbenz(a)anthracene, CAS-RN: 57-97-6, DTXSID1020510
|
563: Aryl hydrocarbon Receptor (AHR) activation causes Premature Ovarian Insufficiency via Bax mediated apoptosis
|
| 837 |
Gluten
|
|
524: Gluten-driven immune activation leading to celiac disease in genetically predisposed individuals
|
| 838 |
Bacterial or viral Infections
|
|
524: Gluten-driven immune activation leading to celiac disease in genetically predisposed individuals
|
| 839 |
Tissue transglutaminase 2 (TG2) enzyme activity
|
|
524: Gluten-driven immune activation leading to celiac disease in genetically predisposed individuals
|
| 840 |
Redox status
|
|
504: SULT1E1 inhibition leading to uterine adenocarcinoma via increased estrogen availability at target organ level
|
| 842 |
CuO nanoparticles
|
|
590: Increase of intracellular copper leading to cuproptosis via interference with energy metabolism
|
| 843 |
Elesclomol
|
|
590: Increase of intracellular copper leading to cuproptosis via interference with energy metabolism
|
| 844 |
Wilson's disease
|
|
590: Increase of intracellular copper leading to cuproptosis via interference with energy metabolism
|